The Australia Infant Phototherapy Device Market is estimated to reach US$ 2.47 billion by 2033, from US$ 1.88 billion in 2024, growing at a CAGR of 3.1% during 2025-2033. This is supported by an increase in cases of neonatal jaundice, increase in awareness about early infant health care, and advances in non-invasive phototherapy treatments in hospitals and neonatal intensive care units in the country.
In Australia, infant phototherapy equipment usage is common and fully integrated into neonatal service, particularly in maternity wards and hospitals. As a result of the excellent level of healthcare, early screening procedures, and increased awareness among parents, phototherapy demand has increased. LED-based phototherapy units are commonly utilized by hospitals, as they are more energy efficient and produce less heat, posing less risk and being more comfortable for infants. The Australian government's emphasis on better neonatal outcomes, and higher birth rates in some areas, continues to propel the adoption of sophisticated phototherapy solutions throughout Australia.
Australia Infant Phototherapy Device Market Outlooks
Infant phototherapy equipment is a medical device employed to treat neonatal jaundice, a prevalent condition in infants characterized by high bilirubin levels in the blood. The devices release blue light waves (usually 460-490 nm) that facilitate the breakdown of excess bilirubin so that it may be excreted from the infant's body. The therapy is safe, non-invasive, and very effective when applied promptly.In Australia, infant phototherapy equipment usage is common and fully integrated into neonatal service, particularly in maternity wards and hospitals. As a result of the excellent level of healthcare, early screening procedures, and increased awareness among parents, phototherapy demand has increased. LED-based phototherapy units are commonly utilized by hospitals, as they are more energy efficient and produce less heat, posing less risk and being more comfortable for infants. The Australian government's emphasis on better neonatal outcomes, and higher birth rates in some areas, continues to propel the adoption of sophisticated phototherapy solutions throughout Australia.
Growth Drivers in Australia Infant Phototherapy Device Market
Increasing Prevalence of Neonatal Jaundice
Neonatal jaundice is a common disorder in newborns throughout Australia, frequently due to premature birth or immaturity of the liver. Early detection and treatment are prioritized by hospitals and clinics to avert complications such as kernicterus. With more babies being screened on birth, the demand for phototherapy devices is increasing. The higher rate of diagnosis, coupled with increased parental and caregiver awareness, accelerates the demand for effective and non-invasive treatment devices. KPMG reviewed recent Australian Bureau of Statistics figures, a total of 289,100 births in Australia for 2023.Advances in Phototherapy Devices Technology
The market is experiencing innovation in phototherapy equipment, such as the application of LED technology, fiber-optic phototherapy blankets, and sophisticated intensity controls. These advances provide improved treatment results, energy efficiency, portability, and infant comfort. Australian hospitals are spending more on such innovations, fueling market growth. The replacement of fluorescent-based with LED-based equipment is particularly significant in urban and rural health facilities. In March 2022, Cook Medical launched The MINC+ Benchtop Incubator for clinical embryologists and IVF clinics across Australia. This kind of product launches is anticipated to drive prenatal care in the country, anticipated to drive market growth over the forecast period.Government Support and Healthcare Infrastructure
Australia's strong public healthcare system, as well as government interventions in neonatal and maternal health, largely facilitate the implementation of infant phototherapy equipment. Public and private hospital procurement inclusion, in addition to funding of rural healthcare outreach, fuel broad access. Programs for training healthcare personnel also ensure proper usage, enhancing results and building trust in their effectiveness nationwide.Challenges in the Australia Infant Phototherapy Device Market
Expensive Equipment and Budget Restraints
With the advantages, the cost of advanced phototherapy equipment - particularly LED-based equipment - is a challenge for small clinics and rural hospitals. Budget constraints can result in underuse or the use of outdated machines. The absence of centralized procurement regulations in certain regions is also a factor in uneven distribution and late upgrades in lower-income or remote areas.Limited Availability in Remote and Indigenous Populations
Healthcare access geographic disparities continue to be a significant issue. Remote and Indigenous populations in Australia might not have direct access to neonatal units or phototherapy equipment. Transporting the newborns to larger centers for treatment can create a delay in receiving it and exposes them to greater chances of complications. This gap has to be filled by investing in mobile phototherapy technology and trained staff to cover underserved populations.Australia Infant Phototherapy Fluorescent Lamps Device Market
Phototherapy devices based on fluorescent lamps were previously the norm in neonatal wards. Although cheaper than LED-based options, they are hotter running and need frequent bulb replacement, raising maintenance costs. Although being phased out in urban areas over time, they still find use in rural or lower-cost institutions. Increasing demand for safer and more efficient units will, however, constrain the growth of this segment.Australia Infant Phototherapy Mobile Device Market
Mobile phototherapy devices provide convenience and are best suited for application in neonatal units where space is scarce or for rural outreach programs. They can be moved conveniently between rooms or institutions, and their use is essential in out-of-the-way places. Portability also assists in home-care settings under supervision. The need for mobile solutions keeps on growing with attempts to decentralize Australia's neonatal care.Australia Infant Phototherapy Fixed Device Market
Fixed phototherapy units are a staple in larger hospitals, providing high-intensity treatment with stability. They are typically installed in NICUs and maternity wards and are suitable for high-volume patient environments. These systems are known for durability and consistent output, but their immobility limits use in flexible care settings. Hospitals with established neonatal departments often prefer these systems for round-the-clock usage.Australia Infant Phototherapy Device Hospital Market
Hospitals continue to be the largest consumers of infant phototherapy devices based on the number of births and availability of NICUs. Public and private hospitals in Australia give utmost importance to upgrading neonatal equipment, including high-intensity low-heat phototherapy systems. Incorporation of such devices into neonatal policy helps in early intervention as well as better outcomes. Government health subsidies and procurement assistance enable growth of this market segment.Victoria Infant Phototherapy Device Market
Victoria, with its high concentration of urban dwellers and robust healthcare system, accounts for a high proportion of the phototherapy device market. Principal cities such as Melbourne have well-developed hospitals and neonatal centers that continuously invest in the most recent technology. Public health programs directed at maternal and child health also contribute to consistent demand in both metropolitan and regional hospitals in the state.Queensland Infant Phototherapy Device Market
Queensland's vast geography necessitates access to neonatal treatment as an imperative both in urban and rural regions. While the larger cities like Brisbane accommodate sophisticated pediatric facilities, there is immense need for phototherapy machines. Even doctors in the countryside are increasingly utilizing mobile as well as LED-based units to enhance patient access to care. Government health departments remain involved in funding and outreach activities.Tasmania Infant Phototherapy Device Market
Tasmania, although less populated, has a high level of healthcare. Both Hobart and Launceston have well-equipped hospitals with latest phototherapy equipment, and smaller clinics use the advantage of mobile units for treating newborn jaundice in their areas. The state government also funds rural outreach services encompassing neonatal screening and treatment facilities, helping to create a consistent market for fixed and mobile phototherapy equipment.Western Australia Infant Phototherapy Device Market
Western Australia's immense and far-flung terrain presents logistical complications in neonatal care. Perthan hospitals are highly equipped, but every attempt to extend care to outlying Aboriginal communities is made. Mobile and compact phototherapy equipment is increasingly being sent into remote areas to fill gaps in the continuum of care. The state's focus on maternal health services and rural outreach supports demand for convenient, effective treatment devices.Market Segmentation
Light Source
- Fluorescent Lamps
- Light Emitting Diodes
- Quartz Halogen Lamps
- Gas Discharge Tubes
Configuration
- Mobile Device
- Fixed Device
End User
- Hospital
- Neonatal Clinics
Top States
- New South Wales
- Victoria
- Queensland
- Western Australia
- South Australia
- Australian Capital Territory
- Tasmania
- Northern Territory
Key Players Analysis (Overviews, Key Persons, Recent Developments, SWOT Analysis, Revenue Analysis)
- Ningbo David Medical Device Co., Ltd
- Koninklijke Philips N.V.
- General Electric Company
- Inapiration Healthcare Group Plc
- Drägerwerk AG & Co. KGaA
- Ibis Medical Equipment and Systems Pvt Ltd
- Weyer GmbH
- Natus Medical Incorporated
Table of Contents
1. Introduction3. Executive Summary11. Value Chain Analysis
2. Research & Methodology
4. Market Dynamics
5. Australia Infant Phototherapy Device Market
6. Market Share Analysis
7. Light Source
8. Configuration
9. End User
10. Top States
12. Porter's Five Forces Analysis
13. SWOT Analysis
14. Pricing Benchmark Analysis
15. Key Players Analysis
Companies Mentioned
The major companies profiled in this Australia Infant Phototherapy Device market report include:- Ningbo David Medical Device Co., Ltd
- Koninklijke Philips N.V.
- General Electric Company
- Inapiration Healthcare Group Plc
- Drägerwerk AG & Co. KGaA
- Ibis Medical Equipment and Systems Pvt Ltd
- Weyer GmbH
- Natus Medical Incorporated
Methodology
In this report, for analyzing the future trends for the studied market during the forecast period, the publisher has incorporated rigorous statistical and econometric methods, further scrutinized by secondary, primary sources and by in-house experts, supported through their extensive data intelligence repository. The market is studied holistically from both demand and supply-side perspectives. This is carried out to analyze both end-user and producer behavior patterns, in the review period, which affects price, demand and consumption trends. As the study demands to analyze the long-term nature of the market, the identification of factors influencing the market is based on the fundamentality of the study market.
Through secondary and primary researches, which largely include interviews with industry participants, reliable statistics, and regional intelligence, are identified and are transformed to quantitative data through data extraction, and further applied for inferential purposes. The publisher's in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of their recommendations and advice.
Primary Research
The primary purpose of this phase is to extract qualitative information regarding the market from the key industry leaders. The primary research efforts include reaching out to participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions. The publisher also established professional corporate relations with various companies that allow us greater flexibility for reaching out to industry participants and commentators for interviews and discussions, fulfilling the following functions:
- Validates and improves the data quality and strengthens research proceeds
- Further develop the analyst team’s market understanding and expertise
- Supplies authentic information about market size, share, growth, and forecast
The researcher's primary research interview and discussion panels are typically composed of the most experienced industry members. These participants include, however, are not limited to:
- Chief executives and VPs of leading corporations specific to the industry
- Product and sales managers or country heads; channel partners and top level distributors; banking, investment, and valuation experts
- Key opinion leaders (KOLs)
Secondary Research
The publisher refers to a broad array of industry sources for their secondary research, which typically includes, however, is not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Patent and regulatory databases for understanding of technical & legal developments
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic new articles, webcasts, and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecasts
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | July 2025 |
| Forecast Period | 2024 - 2033 |
| Estimated Market Value ( USD | $ 1.88 Billion |
| Forecasted Market Value ( USD | $ 2.47 Billion |
| Compound Annual Growth Rate | 3.1% |
| Regions Covered | Australia |
| No. of Companies Mentioned | 9 |
